MediWound Secures Additional U.S. Department of Defense Funding to Advance NexoBrid® Development for the U.S. Army

3 months ago

Awarded additional $6.7 million to advance NexoBrid as a non-surgical field care solution; R&D project budget increased to $14.4 millionYAVNE,…

Apellis Pharmaceuticals to Host a Fireside Chat at the Goldman Sachs Healthcare C-Suite Unscripted Conference

3 months ago

WALTHAM, Mass., Dec. 28, 2023 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will host a…

MannKind Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference

3 months ago

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Dec. 28, 2023 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) a company focused on…

Sequana Medical submits Premarket Approval application to US FDA for alfapump® in recurrent or refractory ascites due to liver cirrhosis

3 months ago

PRESS RELEASEREGULATED INFORMATION – INSIDE INFORMATION28 December 2023, 07:00 am CET Pending FDA approval, alfapump could become the first active…

Profound Medical Announces Pricing of US$20 Million Public Offering of Common Shares

3 months ago

TORONTO, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; NASDAQ:PROF) (“Profound” or the “Company”) today announced the pricing…

LiveCare Inc. Expands Telehealth Services Across Multiple States, Welcomes Dr. Nina Patel, and Celebrates Patient Acquisition Milestones

3 months ago

Venice, FL, USA, Dec. 27, 2023 (GLOBE NEWSWIRE) --  LiveCare Inc. (OTC:LVCE), a prominent leader in telehealth and remote patient…

Quipt Home Medical Corp. Announces Filing of Preliminary Base Shelf Prospectus to Replace Recently Expired Base Shelf Prospectus

3 months ago

CINCINNATI, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT; TSX: QIPT), a U.S. based…

CVRx to Present at the 42nd Annual J.P. Morgan Healthcare Conference

3 months ago

MINNEAPOLIS, Dec. 27, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and…

Profound Medical Announces Proposed Public Offering of Common Shares

3 months ago

TORONTO, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; NASDAQ:PROF) (“Profound” or the “Company”) is pleased to announce…

ResMed Announces Participation in the 42nd Annual J.P. Morgan Healthcare Conference

3 months ago

SAN DIEGO, Dec. 27, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer…